化学名称: 2-((4-(3-Methoxypropoxy)-3-methyl-1-oxidopyridin-2-yl)sulfinyl)-1H-benzo[d]imidazole 1-oxide
微笑: O=S(C1=NC2=CC=CC=C2[NH+]1[O-])C3=C(C)C(OCCCOC)=CC=[N+]3[O-]
印地语: InChI=1/C30H34ClN3O8/c1-4-42-30(39)26-23(34-18(2)24(29(38)40-3)25(26)21-11-7-8-12-22(21)31)17-41-16-14-33-28(37)20-10-6-5-9-19(20)27(36)32-13-15-35/h5-12,25,34-35H,4,13-17H2,1-3H3,(H,32,36)(H,33,37)
Identification, isolation and characterization of new impurity in rabeprazole sodium
P. SreenivasaRao, Uttam KumarRay, P. BadarinadhGupta, D.V.N. SrinivasaRao, AminulIslam, PradeepRajput, K.Mukkanti
Journal of Pharmaceutical and Biomedical Analysis Volume 52, Issue 4, 1 August 2010, Pages 620-624
Development and validation of a stability indicating hplc method for the estimation of rabeprazole impurities in pharmaceutical dosage forms by design of experiments
T.v. raghava raju, s.raja kumar1, i.mrutyunjaya rao, n.someswara rao
Asian J Pharm Clin Res, Vol 6, Suppl4, 2013, 43-51
Identification and characterization of stressed degradation products of rabeprazole using LC-ESI/MS/MS and 1H-NMR experiments: in vitro toxicity evaluation of major degradation products
Murali Mohan Bhandi,a Roshan M. Borkar,a G. Shankar,a Snehal Raut,b Narayana Nageshc and R. Srinivas*
RSC Adv., 2016,6, 10719-10735
A Validated RP-HPLC Method for Simultaneous Quantification of Three Potential Genotoxic N-Oxides in Key Intermediate of Rabeprazole sodium
Karri Visweswara Rao1,2* , K Padmaja Reddy1 , Y Ravindra kumar1 , N Rajan
Journal of Pharmacy Research 2012,5(11),5206-5209